Developing transformative treatments for people with neuropsychiatric disorders

At Neuphoria Therapeutics, we are dedicated to pioneering breakthrough therapies that address the complex needs of individuals affected by neuropsychiatric disorders. By focusing on novel approaches and advancing scientific understanding, we aim to deliver medicines that offer lasting relief and hope for a brighter, healthier future.

A GROWING HEALTH CRISIS

Stress and anxiety disorders affect nearly one in four U.S. adults each year, profoundly impacting our daily lives.


Available treatments such as Selective Serotonin Reuptake Inhibitors (SSRIs)
and benzodiazepines, offer some benefits to patients but can sometimes result in
more issues than they resolve.

We are pioneering a breakthrough solution.

BNC210, a first-of-its-kind, well-tolerated anti-anxiety medication, is designed to restore balance in brain chemistry, providing rapid relief from anxiety symptoms without the common pitfalls of sedation, cognitive impairment, or addiction.

Emerging features and benefits

01

Broad-Spectrum Anti-Anxiety & Anti-Stress Efficacy

Effective across a range of anxiety disorders, including PTSD, social anxiety disorder (SAD) and more

02

Rapid Onset & Flexible Dosing

Fast-acting proprietary tablet formulation can be taken “as-needed” or regularly, allowing for customizable treatment.

03

No Cognitive or Addiction Risks

Delivers relief without sedation, addiction potential,
or mental fog.

04

New Mechanism of Action

Targets neurotransmitter balance in a novel way, filling critical gaps in current mental health treatments.

Contact us today

Discover how our groundbreaking technology is transforming mental health—contact us today to learn more.